Mifepristone inhibits GRβ coupled prostate cancer cell proliferation

Journal of Urology

Volumn 188, Issue 3, 2012, Pages 981-988

  Ligr, Martin ^a   Li, Yirong ^a   Logan, Susan K ^a   Taneja, Samir ^a   Melamed, Jonathan ^a   Lepor, Hebert ^a   Garabedian, Michael J ^a   Lee, Peng ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gene expression; glucocorticoid; mifepristone; prostate; prostatic neoplasms; receptors

Indexed keywords

ANDROGEN RECEPTOR; DEXAMETHASONE; GLUCOCORTICOID RECEPTOR BETA; MESSENGER RNA; MIFEPRISTONE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

CELL PROLIFERATION; HORMONE ANTAGONISTS; HUMANS; MALE; MIFEPRISTONE; PROSTATIC NEOPLASMS; RECEPTORS, GLUCOCORTICOID; TUMOR CELLS, CULTURED;

EID: 84864955704     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.04.102     Document Type: Article

References (30)

1. J.T. Isaacs The biology of hormone refractory prostate cancer Why does it develop? Urol Clin North Am 26 1999 263
2. E. Kassi, P. Moutsatsou Glucocorticoid receptor signaling and prostate cancer Cancer Lett 302 2011 1
3. M. Fakih, C.S. Johnson, D.L. Trump Glucocorticoids and treatment of prostate cancer: a preclinical and clinical review Urology 60 2002 553
4. S. Chen, J. Wang, G. Yu Androgen and glucocorticoid receptor heterodimer formation A possible mechanism for mutual inhibition of transcriptional activity J Biol Chem 272 1997 14087
5. K. Nishimura, N. Nonomura, E. Satoh Potential mechanism for the effects of dexamethasone on growth of androgen-independent prostate cancer J Natl Cancer Inst 93 2001 1739
6. Z. Li, Y. Chen, D. Cao Glucocorticoid up-regulates transforming growth factor-beta (TGFβ) type II receptor and enhances TGFβ signaling in human prostate cancer PC-3 cells Endocrinology 147 2006 5259
7. A. Yano, Y. Fujii, A. Iwai Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells Clin Cancer Res 12 2006 3003
8. B.J. Feldman, D. Feldman The development of androgen-independent prostate cancer Nat Rev Cancer 1 2001 34
9. X.Y. Zhao, P.J. Malloy, A.V. Krishnan Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor Nat Med 6 2000 703
10. K.L. Gross, N.Z. Lu, J.A. Cidlowski Molecular mechanisms regulating glucocorticoid sensitivity and resistance Mol Cell Endocrinol 300 2009 7
11. R.H. Oakley, J.A. Cidlowski Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids J Biol Chem 286 2011 3177
12. R.H. Oakley, M. Sar, J.A. Cidlowski The human glucocorticoid receptor beta isoform Expression, biochemical properties, and putative function J Biol Chem 271 1996 9550
13. C.M. Bamberger, A.M. Bamberger, M. de Castro Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans J Clin Invest 95 1995 2435
14. L.J. Lewis-Tuffin, C.M. Jewell, R.J. Bienstock Human glucocorticoid receptor beta binds RU-486 and is transcriptionally active Mol Cell Biol 27 2007 2266
15. Y. Peng, C.X. Li, F. Chen Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70β Am J Pathol 172 2008 225
16. A.O. Brinkmann, L.J. Blok, P.E. de Ruiter Mechanisms of androgen receptor activation and function J Steroid Biochem Mol Biol 69 1999 307
17. N.J. McKenna, J. Xu, Z. Nawaz Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions J Steroid Biochem Mol Biol 69 1999 3
18. P. Alen, F. Claessens, E. Schoenmakers Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1a with multiple steroid receptors and identification of an internally deleted ELE1b isoform Mol Endocrinol 13 1999 117
19. M. Ligr, Y. Li, X. Zou Tumor suppressor function of androgen receptor coactivator ARA70α in prostate cancer Am J Pathol 176 2010 1891
20. S. Lu, S.Y. Tsai, M.J. Tsai Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells Endocrinology 140 1999 5054
21. Y. Peng, L. Chiriboga, H. Yee Androgen receptor coactivator ARA70α and ARA70β isoform-specific antibodies: new tools for studies of expression and immunohistochemical localization Appl Immunohistochem Mol Morphol 16 2008 7
22. C. Rivers, A. Levy, J. Hancock Insertion of an amino acid in the DNA-binding domain of the glucocorticoid receptor as a result of alternative splicing J Clin Endocrinol Metab 84 1999 4283
23. Y. Gu, H. Li, J. Miki Phenotypic characterization of telomerase- immortalized primary non-malignant and malignant tumor-derived human prostate epithelial cell lines Exp Cell Res 312 2006 831
24. T.Z. Yan, F.S. Jin, L.P. Xie Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer Urol Int 81 2008 228
25. A. Dovio, M.L. Sartori, S. De Francia Differential expression of determinants of glucocorticoid sensitivity in androgen-dependent and androgen-independent human prostate cancer cell lines J Steroid Biochem Mol Biol 116 2009 29
26. O. Sartor, M. Weinberger, A. Moore Effect of prednisone on prostate-specific antigen in patients with hormone-refractory prostate cancer Urology 52 1998 252
27. K. Nishimura, N. Nonomura, Y. Yasunaga Low doses of oral dexamethasone for hormone-refractory prostate carcinoma Cancer 89 2000 2570
28. Y. Taniguchi, Y. Iwasaki, M. Tsugita Glucocorticoid receptor-beta and receptor-gamma exert dominant negative effect on gene repression but not on gene induction Endocrinology 151 2010 3204
29. C.A. Longui, A. Vottero, P.C. Adamson Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia Horm Metab Res 32 2000 401
30. M.E. Taplin, J. Manola, W.K. Oh A phase II study of mifepristone (RU-486) in castration-resistant prostate cancer, with a correlative assessment of androgen-related hormones BJU Int 101 2008 1084